Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies.

MLA

Ben-Horin, Shomron, et al. “Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies.” Journal of Crohn’s & Colitis, vol. 12, no. 12, Nov. 2018, pp. 1410–17. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjy122.

APA

Ben-Horin, S., Van Assche, G., Chowers, Y., Fudim, E., Ungar, B., Picard, O., Yavzori, M., Kopylov, U., Mao, R., Chen, M.-H., Peled, Y., Gueta, I., Eliakim, R., Loebstein, R., & Markovits, N. (2018). Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies. Journal of Crohn’s & Colitis, 12(12), 1410–1417. https://doi.org/10.1093/ecco-jcc/jjy122

Chicago

Ben-Horin, Shomron, Gert Van Assche, Yehuda Chowers, Ella Fudim, Bella Ungar, Orit Picard, Miri Yavzori, et al. 2018. “Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies.” Journal of Crohn’s & Colitis 12 (12): 1410–17. doi:10.1093/ecco-jcc/jjy122.